Advertiser / Brand
Kimberly-Clark vs P&G
Structured technology and market comparison · 2026
Direct Feature Comparison
Kimberly-Clark · vs · P&GConsumer goods manufacturer focused on tissue, hygiene and personal care.
Global consumer goods company selling household and personal care brands.
Analyze all overlapping signals and tech stacks for Kimberly-Clark and P&G
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Kimberly-Clark and P&G?
When comparing Kimberly-Clark and P&G, both platforms operate within the Advertiser / Brand ecosystem. Kimberly-Clark is positioned as Consumer goods manufacturer focused on tissue, hygiene and personal care, whereas P&G focuses on Global consumer goods company selling household and personal care brands. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Kimberly-Clark and P&G?
When evaluating Kimberly-Clark and P&G, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Kimberly-Clark and P&G compare?
Kimberly-Clark is headquartered in United States (founded in 1872) with >5,000 employees. P&G is based in United States (founded in 1837) with >5,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Kimberly-Clark vs P&G
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Kimberly-Clark
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-11-05)
On November 5, 2026, Kimberly-Clark Corporation filed a Current Report on Form 8-K under Item 2.02 (Results of Operations and Financial Condition) announcing its financial results for the third quarter ended September 30, 2026. The detailed financial press release was furnished as Exhibit 99.1. In accordance with standard SEC furnishing rules, the information and accompanying exhibit are not deemed 'filed' for liability purposes under Section 18 of the Exchange Act, nor are they incorporated by reference into registration statements under the Securities Act of 1933.
- Kimberly-Clark Corporation furnished its quarterly earnings release for the period ended September 30, 2026, via Exhibit 99.1 on November 5, 2026.
- The filing was executed under Item 2.02 by Senior Vice President and Chief Financial Officer Nelson Urdaneta.
- Information provided in the filing is formally furnished rather than filed, excluding it from Section 18 liabilities of the Securities Exchange Act of 1934.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-11-02)
On November 2, 2026, Kimberly-Clark Corporation (K-C) completed its acquisition of Kenvue Inc. Under the merger terms, Kenvue shareholders received $3.50 in cash and 0.14625 shares of K-C common stock per share, requiring K-C to issue approximately 281,060,840 common shares. In connection with the transaction, K-C's Board approved the Kenvue Integration Program through December 31, 2029, expecting cumulative pre-tax restructuring and integration charges of approximately $3.1 billion ($2.5 billion in cash and $0.6 billion non-cash) alongside $1.4 billion in related capital expenditures to achieve targeted operational synergies by 2030. Governance and compensatory actions accompanying the close include the appointment of three former Kenvue directors—Richard E. Allison, Jr., Larry J. Merlo, and Kirk L. Perry—to K-C's Board, replacing three resigning directors. Furthermore, K-C granted premium-priced, nonqualified stock options to executive leadership, including $6.6 million in grant value to CEO Michael Hsu, with exercise prices set at a minimum of $120.00 or 110% of the grant-date stock price, vesting December 1, 2029.
- K-C completed the acquisition of Kenvue Inc., issuing approximately 281,060,840 K-C common shares and paying $3.50 in cash plus 0.14625 K-C shares per Kenvue share.
- The Board approved the Kenvue Integration Program through December 31, 2029, projecting $3.1 billion in pre-tax charges ($2.5 billion cash, $0.6 billion non-cash) and $1.4 billion in capital expenditures.
- Three Kenvue directors were appointed to K-C's Board (replacing three resigning directors), and executives were awarded premium-priced stock options (including $6.6M in grant value to CEO Michael Hsu) with exercise prices at the greater of $120.00 or 110% of the Grant Date market price.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Kimberly-Clark (2026-11-04)
On November 4, 2026, Kimberly-Clark Corporation completed private exchange offers and consent solicitations covering $7.0 billion aggregate principal amount of senior notes originally issued by Kenvue Inc. The transaction follows the November 2, 2026 closing of Kimberly-Clark's merger with Kenvue, in which Kenvue became a direct wholly owned subsidiary (renamed Kenvue LLC). In the exchange offers, Kimberly-Clark accepted and canceled approximately $6.376 billion of Kenvue notes in exchange for newly issued, pari passu Kimberly-Clark senior notes across seven tranches maturing between 2028 and 2063 with coupon rates from 4.850% to 5.200%. Concurrent amendments stripped substantially all restrictive covenants, default provisions, and SEC reporting requirements from the remaining $623.66 million of unexchanged Kenvue notes.
- Kimberly-Clark completed the exchange of $6,375,992,000 across seven tranches of Kenvue senior notes into new Kimberly-Clark senior notes with matching maturities (2028-2063) and interest rates (4.850%-5.200%).
- A total of $623,661,000 in aggregate principal amount of Kenvue notes remains outstanding across seven series following the settlement.
- The operative Third Supplemental Indenture stripped substantially all restrictive covenants, certain events of default, and SEC reporting obligations from remaining Kenvue notes.
P&G
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for P&G (2026-10-30)
On October 30, 2026, The Procter & Gamble Company closed a multi-tranche underwritten public debt offering totaling $4.0 billion in aggregate principal amount under its Form S-3 shelf registration. The issuance comprises four tranches: $750 million of 5.125% Notes due 2031, $750 million of 5.300% Notes due 2033, $1.25 billion of 5.450% Notes due 2036, and $1.25 billion of 5.900% Notes due 2056. The large-scale capital raise locks in medium- and long-term liquidity across 5-year, 7-year, 10-year, and 30-year maturities. This debt financing provides P&G with substantial balance sheet flexibility to support general corporate purposes, debt refinancing, and operational capital allocation requirements.
- P&G closed an underwritten public offering of $4.0 billion in total aggregate principal across four tranches on October 30, 2026.
- The offering includes $750M of 5.125% Notes due 2031, $750M of 5.300% Notes due 2033, $1.25B of 5.450% Notes due 2036, and $1.25B of 5.900% Notes due 2056.
- The debt was issued under P&G's Form S-3 registration statement (Registration No. 333-299472) with legal opinions filed by internal counsel and Fried, Frank, Harris, Shriver & Jacobson LLP.
- ·SEC APIfinancials
10-Q Financial Filing Analysis for P&G (2026-10-22)
For the first fiscal quarter ended September 30, 2026, The Procter & Gamble Company reported consolidated net sales of $23.28 billion, up 4.0% year-over-year, driven by a 2.4% unit volume increase, 1.1% positive geographic mix, and 0.4% higher pricing. Operating income rose 1.4% to $5.94 billion, while gross margin contracted 160 basis points to 49.8% due to higher commodity costs and product/packaging investments, partially offset by manufacturing productivity gains. Net earnings attributable to P&G declined marginally to $4.73 billion, while diluted EPS increased 1% to $1.97 (Core EPS rose 1% to $2.00). Operating cash flow reached $5.77 billion with free cash flow of $4.40 billion, demonstrating solid 93% free cash flow productivity. Subsequent to quarter-end on October 1, 2026, P&G completed the $3.9 billion all-cash acquisition of premium wellness brand Thorne. The company also progressed its two-year $2.0 billion portfolio and productivity restructuring plan, which aims to reduce up to 7,000 non-manufacturing personnel by the end of fiscal 2027.
- Net sales rose 4.0% year-over-year to $23.28 billion, supported by 2.4% volume growth and 4.0% organic sales growth.
- Gross margin compressed by 160 basis points to 49.8%, impacted by commodity headwinds and packaging investments, though buffered by SG&A leverage to deliver $5.94 billion in operating income.
- Closed the $3.9 billion all-cash acquisition of wellness supplement maker Thorne on October 1, 2026, integrating it into Personal Health Care.
- ·SEC APIfinancials
8-K Financial Filing Analysis for P&G (2026-10-16)
The Procter & Gamble Company filed a Form 8-K reporting the final voting results from its Annual Meeting of Shareholders held on October 13, 2026. Shareholders approved all management-sponsored proposals, including the election of 12 directors for one-year terms, the ratification of the independent registered public accounting firm, and the advisory approval of executive compensation ('Say on Pay'). Conversely, all three shareholder-sponsored proposals—addressing lower thresholds for special meetings, eligibility thresholds for shareholder proposal proponents, and annual reporting on charitable contributions—were defeated by substantial margins.
- All 12 director nominees, including Ashley McEvoy (1.64B votes for) and Joseph Jimenez (1.56B votes for), were elected to one-year terms on the Board.
- Executive compensation ('Say on Pay') was approved with 1,514,086,600 votes in favor, 138,017,439 against, and 13,038,485 abstentions.
- Three shareholder proposals were rejected, including a measure to lower the special meeting threshold (608.5M votes for vs. 1.04B against) and a charitable contribution disclosure proposal (defeated with 1.57B votes against).
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Kimberly-Clark and P&G share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks